Ilaria Zanotti
Overview
Explore the profile of Ilaria Zanotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Papotti B, Escola-Gil J, Julve J, Poti F, Zanotti I
Nutrients
. 2021 Aug;
13(8).
PMID: 34444804
Reverse cholesterol transport (RCT) is a physiological mechanism protecting cells from an excessive accumulation of cholesterol. When this process begins in vascular macrophages, it acquires antiatherogenic properties, as has been...
12.
Bonilha I, Zimetti F, Zanotti I, Papotti B, Sposito A
J Clin Med
. 2021 Jun;
10(11).
PMID: 34063950
High density lipoproteins (HDLs) are commonly known for their anti-atherogenic properties that include functions such as the promotion of cholesterol efflux and reverse cholesterol transport, as well as antioxidant and...
13.
Breder I, Breder J, Bonilha I, Munhoz D, Medorima S, Oliveira D, et al.
Ther Adv Chronic Dis
. 2020 Oct;
11:2040622320959248.
PMID: 33062236
Background: Patients with type 2 diabetes mellitus (T2DM) remain at increased cardiovascular residual risk and endothelial dysfunction, even after optimizing metabolic control and treatment by sodium-glucose-2 transporter inhibitors (SGLT2-is). The...
14.
Zanotti I, Marando S, Remaggi G, Bergonzi C, Bernini F, Bettini R, et al.
Biochim Biophys Acta Gen Subj
. 2020 Sep;
1865(1):129734.
PMID: 32956750
Background: The investigation of the interactions between cells and active materials is pivotal in the emerging 3D printing-biomaterial application fields. Here, lipidomics has been used to explore the early impact...
15.
Bergonzi C, Remaggi G, Graiff C, Bergamonti L, Potenza M, Ossiprandi M, et al.
Nanomaterials (Basel)
. 2020 May;
10(5).
PMID: 32353965
Here, a formulation of silver nanoparticles (AgNPs) and two natural polymers such as alginate (ALG) and nanocrystalline cellulose (CNC) was developed for the 3D printing of scaffolds with large surface...
16.
Giorgio C, Zanotti I, Lodola A, Tognolini M
Expert Opin Ther Targets
. 2020 Mar;
24(5):403-415.
PMID: 32197575
: The Eph-ephrin is a cell-cell communication system generating a forward signal in cell expressing Eph receptors and a reverse signal in ephrin-ligand expressing cells. While clearly involved in the...
17.
de Lima-Junior J, Virginio V, Moura F, Bertolami A, Bertolami M, Coelho-Filho O, et al.
Nutr Metab Cardiovasc Dis
. 2019 Nov;
30(2):254-264.
PMID: 31753789
Background And Aim: Obesity-related decline in high-density lipoprotein (HDL) functions such as cholesterol efflux capacity (CEC) has supported the notion that this lipoprotein dysfunction may contribute for atherogenesis among obese...
18.
Sposito A, Zimetti F, Barreto J, Zanotti I
Adv Clin Chem
. 2019 Sep;
92:105-140.
PMID: 31472752
The reduction of plasma apolipoprotein B (apoB) containing lipoproteins has long been pursued as the main modifiable risk factor for the development of cardiovascular disease (CVD). This has led to...
19.
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
Sposito A, de Lima-Junior J, Moura F, Barreto J, Bonilha I, Santana M, et al.
Arterioscler Thromb Vasc Biol
. 2019 Jun;
39(8):1550-1564.
PMID: 31189429
Despite decades of therapeutic advances, myocardial infarction remains a leading cause of death worldwide. Recent studies have identified HDLs (high-density lipoproteins) as a potential candidate for mitigating coronary ischemia/reperfusion injury...
20.
Sposito A, Carmo H, Barreto J, Sun L, Carvalho L, Feinstein S, et al.
Cardiovasc Drugs Ther
. 2019 Feb;
33(3):371-381.
PMID: 30778806
It is now apparent that a variety of deleterious mechanisms intrinsic to myocardial infarction (MI) exists and underlies its high residual lethality. Indeed, despite effective coronary patency therapies, ischemia and...